# Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026
Canonical URL: https://biopharmsignal.com/news/HCAT/health-catalyst-to-announce-first-quarter-2026-operating-results-and-host-confer-a23ecc29
Ticker: HCAT
Company: Health Catalyst
Source: Health Catalyst
Published: 2026-05-01 12:00 EST
## Summary

Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to...

## Article Body
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.

Conference Call Details

The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID “HCATQ126.” A live audio webcast will be available online at https://ir.healthcatalyst.com/ . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Health Catalyst

Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action.

Health Catalyst Investor Relations Contact:

Stephanie St. Clair Finance and Investor Relations, SVP ir@healthcatalyst.com

Health Catalyst Media Contact:

‍Kathryn Larson Director of Public Relations and Communications media@healthcatalyst.com
## Recent Company News
- 2026-06-16 20:05 EST — [Health Catalyst to Participate in Upcoming Investor Conference](https://biopharmsignal.com/news/HCAT/health-catalyst-to-participate-in-upcoming-investor-conference-70ce0f58) — Source: Health Catalyst
- 2026-06-04 13:03 EST — [Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation](https://biopharmsignal.com/news/HCAT/health-catalyst-to-divest-vitalware-for-147-million-accelerating-strategic-trans-3fdcad3f) — Source: Health Catalyst
- 2026-05-11 20:05 EST — [Health Catalyst Reports First Quarter 2026 Results](https://biopharmsignal.com/news/HCAT/health-catalyst-reports-first-quarter-2026-results-bc27d6b4) — Source: Health Catalyst
- 2026-05-01 12:00 EST — [Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026](https://biopharmsignal.com/news/HCAT/health-catalyst-to-announce-first-quarter-2026-operating-results-and-host-confer-a23ecc29) — Source: Health Catalyst
- 2026-04-30 13:27 EST — [Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors](https://biopharmsignal.com/news/HCAT/health-catalyst-appoints-steve-nelson-president-of-aetna-to-its-board-of-directo-59637695) — Source: Health Catalyst
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)